Design Therapeutics, Inc. DSGN Accrued Liabilities & Other
Accrued Liabilities & Other at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s accrued liabilities & other.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s accrued liabilities & other?
- Design Therapeutics, Inc. (DSGN) reported accrued liabilities & other of $7.91M in Q1 2026.
- How has Design Therapeutics, Inc.'s accrued liabilities & other changed year-over-year?
- Design Therapeutics, Inc.'s accrued liabilities & other increased by 56.5% year-over-year, from $5.06M to $7.91M.
- What is the long-term trend for Design Therapeutics, Inc.'s accrued liabilities & other?
- Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s accrued liabilities & other has grown at a 63.1% compound annual growth rate (CAGR), from $931K to $10.74M.
- What does accrued liabilities & other mean?
- Combined accrued expenses and miscellaneous current liabilities not classified in specific categories.